OpenAI Eyes a Possible $1 Trillion IPO by 2027 While Burning Billions: Legitimate AI Bet or a Bubble Waiting to Pop?
OpenAI, last valued at roughly 852 billion dollars in a March 2026 funding round, is reportedly preparing for an IPO that could target a valuation of up to 1 trillion dollars and raise 60 billion dollars or more, possibly in late 2026 or 2027. The company's 2025 revenue grew 233 percent to about 20 billion dollars, but it lost roughly 1.22 dollars for every dollar of revenue, and 2026 losses are projected around 14 billion dollars, with cumulative losses potentially reaching 115 billion dollars by 2029 before profitability arrives sometime in the 2030s. OpenAI also missed its own 2026 revenue target of 30 billion dollars, and faces intensifying competition from Google's Gemini, which has reportedly reached about 900 million users, as well as Anthropic and others. Supporters see a category-defining company investing aggressively in a genuine technological shift; skeptics point to governance turmoil, heavy dependence on Microsoft, talent departures, and a widening gap between hype and financial fundamentals.
Poll as Guest Infographics
Similar to hewsay's "OpenAI Eyes a Possible $1 Trillion IPO by 2027 While Burning Billions: Legitimate AI Bet or a Bubble Waiting to Pop?"
# OpenAI reportedly aiming for 1 trillion dollar IPO valuation is this still an opportunity : r/stocks. Skip to main contentOpenAI reportedly aiming for 1 trillion dollar IPO valuation is this still an opportunity : r/stocks. Open menu Open navigationGo to Reddit Home. Get App...
# The AI history that explains fears of a bubble. Concerns among some investors are mounting that the AI sector, which has singlehandedly prevented the economy from sliding into recession, has become an unsustainable bubble. Nvidia, the main supplier of chips used in AI, becam...
Moderna Stock Exploded 177% in One Day on a Cancer Vaccine Breakthrough -- Is This Justified Science, Pure Hype, or a Short-Squeeze Overreaction?
On August 19, 2026, Moderna's shares skyrocketed as much as 177% in a single session -- the biggest one-day gain in the company's history -- after it and Merck announced that their personalized mRNA cancer vaccine, intismeran autogene, hit its primary and secondary endpoints in combination with Keytruda in a Phase 3 melanoma trial of over 1,100 patients. The move added roughly $44 billion in market value in hours and instantly vaulted Moderna past every Wall Street analyst's price target, since the stock had carried only a consensus "Hold" rating and a $52.95 average target just the day before. Short sellers, caught badly offside, are estimated to have lost around $5.5 billion in the squeeze. Is this a legitimate re-rating of a real oncology breakthrough, an overexcited bet on a speculative pipeline still years from approval, or a technically-driven overreaction fueled by short covering that could partially unwind?
Poll as Guest Infographics
Similar to hewsay's "Moderna Stock Exploded 177% in One Day on a Cancer Vaccine Breakthrough -- Is This Justified Science, Pure Hype, or a Short-Squeeze Overreaction?"
# AI is curing cancer (Moderna's Intismeran vaccine). It doesn't seem like the connection between AI and Moderna and Merck's breakthrough with its skin cancer vaccine, Intismeran, has been made. Moderna stock (MRNA) has gone up 83% year to date on the news that the vaccine is ...
# I Just Bought $510K Worth of Moderna Stock. r/ModernaStock - I Just Bought $510K Worth of Moderna Stock. Moderna (MRNA) is completely undervalued right now. It's clear that short sellers are driving down the price in the short term, but in the mid-to-long term, I believe the...